Funiculosin, a new antibiotic. I. Isolation, biological and chemical properties (studies on antiviral and antitumor antibiotics. 8).
D000818:Animals; D000900:Anti-Bacterial Agents / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D000998:Antiviral Agents; D001230:Aspergillus / Q000187:drug effects; D001412:Bacillus subtilis / Q000187:drug effects; D002175:Candida / Q000187:drug effects; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D002642:Chick Embryo; D002845:Chromatography; D003454:Cryptococcus / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D006168:Guinea Pigs; D006367:HeLa Cells; D006564:Herpesviridae / Q000187:drug effects; D007259:Infrared Rays; D051379:Mice; D009522:Newcastle disease virus / Q000187:drug effects; D010407:Penicillium / Q000032:analysis; D012440:Saccharomyces / Q000187:drug effects; D013057:Spectrum Analysis; D014249:Trichophyton / Q000187:drug effects; D014616:Vaccinia virus / Q000187:drug effects
D000900:Anti-Bacterial Agents; D000998:Antiviral Agents